Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Baratta

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
International Journal of Antimicrobial Agents|July 7, 2019
Off-label use of ceftaroline fosamil: A systematic reviewArianna Pani, Fabrizio Colombo, Francesca Agnelli, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Sex-Related Differences in the Association between Metabolic Syndrome and Gallstone DiseaseFrancesco Baratta, Daniele Pastori, Nicholas Cocomello, et al.
International Journal of Molecular Sciences|March 11, 2023
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular RiskFrancesco Baratta, Nicholas Cocomello, Mattia Coronati, et al.
Internal and Emergency Medicine|March 13, 2021
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort studyDaniele Pastori, Angela Sciacqua, Rossella Marcucci, et al.
International Journal of Molecular Sciences|November 26, 2015
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?Francesco Baratta, Daniele Pastori, Licia Polimeni, et al.
Nutrients|September 15, 2020
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative StressDomenico Ferro, Francesco Baratta, Daniele Pastori, et al.
Journal of Clinical Medicine|October 27, 2018
Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver DiseaseDaniele Pastori, Francesco Baratta, Marta Novo, et al.
Biomedicines|March 25, 2022
Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver DiseaseFrancesco Baratta, Laura D'Erasmo, Alessia Di Costanzo, et al.
International Journal of Environmental Research and Public Health|September 10, 2021
Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio StudyFrancesco Baratta, Domenico Ferro, Daniele Pastori, et al.
Annals of Vascular Surgery|October 20, 2019
Incidence of Post-Implantation Syndrome with Different Endovascular Aortic Aneurysm Repair Modalities and Devices and Related Etiopathogenetic ImplicationsOmbretta Martinelli, Alessia Di Girolamo, Cristina Belli, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Antimicrobial Agents|July 7, 2019
Off-label use of ceftaroline fosamil: A systematic reviewArianna Pani, Fabrizio Colombo, Francesca Agnelli, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Sex-Related Differences in the Association between Metabolic Syndrome and Gallstone DiseaseFrancesco Baratta, Daniele Pastori, Nicholas Cocomello, et al.
International Journal of Molecular Sciences|March 11, 2023
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular RiskFrancesco Baratta, Nicholas Cocomello, Mattia Coronati, et al.
Internal and Emergency Medicine|March 13, 2021
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort studyDaniele Pastori, Angela Sciacqua, Rossella Marcucci, et al.
International Journal of Molecular Sciences|November 26, 2015
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?Francesco Baratta, Daniele Pastori, Licia Polimeni, et al.
Nutrients|September 15, 2020
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative StressDomenico Ferro, Francesco Baratta, Daniele Pastori, et al.
Journal of Clinical Medicine|October 27, 2018
Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver DiseaseDaniele Pastori, Francesco Baratta, Marta Novo, et al.
Biomedicines|March 25, 2022
Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver DiseaseFrancesco Baratta, Laura D'Erasmo, Alessia Di Costanzo, et al.
International Journal of Environmental Research and Public Health|September 10, 2021
Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio StudyFrancesco Baratta, Domenico Ferro, Daniele Pastori, et al.
Annals of Vascular Surgery|October 20, 2019
Incidence of Post-Implantation Syndrome with Different Endovascular Aortic Aneurysm Repair Modalities and Devices and Related Etiopathogenetic ImplicationsOmbretta Martinelli, Alessia Di Girolamo, Cristina Belli, et al.
Pageof 9